Bajaj Healthcare launches 'Ivejaj' tablets for COVID treatment

Bajaj Healthcare said it has successfully developed the active pharmaceutical ingredient and the formulation for Ivermectin through its own in-house R&D team.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eltgi4
via IFTTT

0 comments:

Post a Comment